Nitroglycerin Controlled Release Tablets 2.6 MG – Nitoryl 2.6 Tablets

NITORYL 2.6 Tablets
Composition:- Nitroglycerin 2.6 mg controlled release

NITORYL 2.6 Tablets – Nitroglycerin Controlled Release Tablets 2.6 MG is a vasodilator commonly used to manage angina, hypertension, and other cardiac issues. After metabolism, it is converted to nitric oxide to help produce cyclic guanosine monophosphate (cGMP), resulting in vasodilation and relaxation of smooth muscles in both arteries and veins. It helps to ease the oxygen supply to the heart and manage the condition of angina, and also prevents coronary artery spasm, decreases preload, and afterload on the heart.

Key Points of Nitroglycerin Controlled Release Tablets – NITORYL 2.6 Tablets
• Dual Vascular Action – Acts on both veins and arteries, effectively reducing myocardial oxygen demand, improving blood supply to the heart, and lowering preload and afterload.
• Controlled Release Advantage – The controlled release formulation ensures consistent and prolonged drug release, offering a quick onset of action, immediate relief, and enhanced patient compliance.
• Superior to Beta Blockers – Provides a better option than beta blockers for the long-term management of angina and other cardiovascular conditions.

Can be Prescribed by:
• Cardiologists
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.